|
 |
|
|||||||
|
|||||||||
© 2004 The American Thoracic Society
Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium
Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Correspondence and requests for reprints should be addressed to Robert P. Schleimer, Ph.D., Northwestern University Feinberg School of Medicine, Division of Allergy-Immunology, 240 East Huron Street, Rm. 2318, Chicago, IL 60611. E-mail: rpschleimer{at}northwestern.edu
Epithelial cells produce molecules that alter the growth and differentiation of mesenchymal cells, trigger the adhesion to endothelial cells and recruitment of inflammatory leukocytes, and regulate the activation of resident and infiltrating inflammatory cells. Recently, it has become clear that the airway epithelium also participates in innate immune responses. Accumulating evidence suggests that epithelial products such as complement, collectins, lysozyme, lactoferrin, secretory leukocyte protease inhibitor, and defensins can lead to localized destruction of microorganisms. While suppressing systemic adaptive immune responses, glucocorticoids exert little or no inhibitory effect on the ability of the epithelium to express these antimicrobial substances and, in some cases, may even elevate their production. Inhaled glucocorticoids generally profoundly inhibit epithelial cell expression of genes of inflammation, including chemokines, cytokines, and enzymes. Glucocorticoids may enhance the sensitivity of the epithelial surface to Toll-like receptor ligands, and they have been found to induce the expression of surfactant proteins A and D in several in vitro and in vivo model systems. Supporting the concept that glucocorticoids enhance innate immunity while suppressing adaptive immunity, these drugs enhance the survival and/or function of neutrophils and alveolar macrophages but induce the apoptosis of airway dendritic cells.
Key Words: adaptive immunity • allergic bronchopulmonary aspergillosis • asthma • chronic obstructive pulmonary disease • chronic rhinosinusitis
This article has been cited by other articles:
|
|
 |
|
  L. McKinley, J. F. Alcorn, A. Peterson, R. B. DuPont, S. Kapadia, A. Logar, A. Henry, C. G. Irvin, J. D. Piganelli, A. Ray, et al. TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice J. Immunol., September 15, 2008; 181(6): 4089 - 4097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. T. Ishmael, X. Fang, M. R. Galdiero, U. Atasoy, W. F. C. Rigby, M. Gorospe, C. Cheadle, and C. Stellato Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation J. Immunol., June 15, 2008; 180(12): 8342 - 8353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Jakiela, R. Brockman-Schneider, S. Amineva, W.-M. Lee, and J. E. Gern Basal Cells of Differentiated Bronchial Epithelium Are More Susceptible to Rhinovirus Infection Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, Q. A. Truong-Tran, B. Tancowny, K. E. Harris, and R. P. Schleimer Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins J. Immunol., July 1, 2007; 179(1): 578 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kato, A. Q. Truong-Tran, A. L. Scott, K. Matsumoto, and R. P. Schleimer Airway Epithelial Cells Produce B Cell-Activating Factor of TNF Family by an IFN-beta-Dependent Mechanism J. Immunol., November 15, 2006; 177(10): 7164 - 7172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Schleimer Innate Immune Responses and Chronic Obstructive Pulmonary Disease: "Terminator" or "Terminator 2"? Proceedings of the ATS, November 1, 2005; 2(4): 342 - 346. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |